Directors, managers, VPs, regulatory affairs personnel, and service providers of the logistics and operations verticals for the biopharma supply chain across Europe and North America are invited to attend the 3rd BioPharma Supply Chain & Logistics Nexus Conference being held April 25-26, 2024, at the Basel Mariott Hotel, Switzerland. The event aims to address critical issues and challenges in the supply chain and logistics within the biopharmaceutical industry.
The event is hosted by BioPharma Nexus, a premier company organizing prestigious conferences aiming to foster networking and business ties between pharmaceutical and biotech companies and their service providers. The focus lies in building robust relations such that the best healthcare services are available to patients worldwide. Service providers, managers, and company heads can identify and connect with partners to foster important scientific and healthcare collaborations.
Benefits of attending the conference:
- Establishing networking and business relations among powerful industry leaders.
- Gain insightful knowledge and learn about the latest trends in the biopharma spectrum.
- Connect with the industry leaders to stay updated with the latest technological advancements as well as the target audience.
- Learn the latest offerings and get innovative ideas and solutions for business operations.
- Showcase your product and business solutions on a unified conference platform.
The 3rd BioPharma Nexus Conference brings together global leaders and experts on the biopharma supply chain to provide invaluable insights. They will explore topics ranging from improving the supply chain transparency and sustainability in temperature-controlled logistics to novel technologies and trends in the pharmaceutical supply chain. Special attention will be given to the issues and opportunities faced by Contract Manufacturing Organizations (CMOs/CDMOs). New entities can leverage the nexus forum to gain visibility and network with key industry stalwarts.
To know more, please visit https://ibn.fm/nPR98
About InvestorWire
InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer
InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]
InvestorWire is powered by IBN